NCT00290849View on ClinicalTrials.gov

ImproveR International (BI-001-IM)

CompletedOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

September 30, 2007

Conditions
Thrombin-specific Anticoagulant Bivalirudin During Percutaneous Coronary Intervention (PCI)
Interventions
DRUG

Bivalirudin

Trial Locations (1)

4000

Nycomed, Roskilde

Sponsors

Lead Sponsor

Nycomed
All Listed Sponsors
lead

Nycomed

INDUSTRY

NCT00290849 - ImproveR International (BI-001-IM) | Biotech Hunter | Biotech Hunter